{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:12:33Z","timestamp":1792725153472,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.semarthrit.2011.08.008","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T20:56:05Z","timestamp":1322772965000},"page":"658-668","source":"Crossref","is-referenced-by-count":45,"title":["Biological Agents in the Management of Felty's Syndrome: A Systematic Review"],"prefix":"10.1016","volume":"41","author":[{"given":"Javier","family":"Narv\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Domingo-Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"G\u00f3mez-Vaquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"L\u00f3pez-Vives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mart\u00edn-Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Miquel","family":"Nolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2011.08.008_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.berh.2004.05.002","article-title":"Felty's syndrome","volume":"18","author":"Balint","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005792-199069020-00001","article-title":"The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations","volume":"69","author":"Campion","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0049-0172(91)90002-H","article-title":"Felty's and pseudo-Felty's syndromes","volume":"21","author":"Rosenstein","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib4","first-page":"1163","article-title":"The clinical course of Felty's syndrome compared to matched controls","volume":"18","author":"Sibley","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2006.01.003","article-title":"Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome","volume":"20","author":"Burks","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/rheumatology\/37.8.908","article-title":"Methotrexate treatment in Felty's syndrome","volume":"37","author":"Wassenberg","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib7","first-page":"983","article-title":"Felty's syndrome: response to low dose oral methotrexate","volume":"16","author":"Isasi","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib8","first-page":"599","article-title":"Oral methotrexate in the treatment of Felty's syndrome","volume":"20","author":"Tan","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/anr.1780320212","article-title":"Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome","volume":"32","author":"Fiechtner","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/art.1780290713","article-title":"Treatment of Felty's syndrome with low-dose oral methotrexate","volume":"29","author":"Allen","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib11","first-page":"200","article-title":"Longterm effect of methotrexate in Felty's syndrome: a 12 year followup","volume":"23","author":"Gerster","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00005792-198603000-00003","article-title":"Parenteral gold therapy in the Felty syndrome","volume":"65","author":"Dillon","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib13","first-page":"20","article-title":"Longterm outcome of treatment of Felty's syndrome with intramuscular gold: case reports and recommendations for management","volume":"32","author":"Almoallim","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib14","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/art.1780300914","article-title":"Felty's syndrome: long-term followup after treatment with auranofin","volume":"30","author":"Bellelli","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib15","first-page":"658","article-title":"A study of the response of the leukopenia of rheumatoid arthritis to gold salt therapy","volume":"8","author":"Mastaglia","year":"1981","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib16","first-page":"868","article-title":"Treatment of Felty's syndrome with leflunomide","volume":"28","author":"Talip","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.2830360315","article-title":"Cyclosporine for the treatment of granulocytopenia in Felty's syndrome","volume":"36","author":"Canvin","year":"1991","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.semarthrit.2011.08.008_bib18","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.3324\/haematol.11819","article-title":"Neutropenia in Felty's syndrome successfully treated with hydroxychloroquine","volume":"92","author":"Mah\u00e9vas","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib19","first-page":"404","article-title":"Salazosulfapyridine-induced remission of Felty's syndrome along with significant reduction in neutrophil-bound immunoglobulin G","volume":"30","author":"Ishikawa","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib20","first-page":"703","article-title":"D-penicillamine in Felty's syndrome","volume":"12","author":"Lakhanpal","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2011.01.006","article-title":"Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus","volume":"10","author":"Newman","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(99)80040-7","article-title":"Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor","volume":"29","author":"Hellmich","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/91.1.49","article-title":"Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF)","volume":"91","author":"Stanworth","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0268-960X(96)90024-7","article-title":"Treatment of the neutropenia of Felty syndrome","volume":"10","author":"Rashba","year":"1996","journal-title":"Blood Rev"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(76)90027-9","article-title":"Felty's syndrome","volume":"61","author":"Gupta","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.1986.00360140083013","article-title":"Lithium carbonate therapy in severe Felty's syndrome","volume":"146","author":"Mant","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/ard.2004.025643","article-title":"Lack of efficacy of rituximab in Felty's syndrome","volume":"64","author":"Sordet","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.rhu.0000200326.17729.76","article-title":"Beneficial response to rituximab in refractory Felty Syndrome","volume":"12","author":"Weinreb","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib29","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/ard.2007.077966","article-title":"Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome","volume":"67","author":"Salama","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MJT.0b013e318164bf32","article-title":"Rituximab is useful in the treatment of Felty's syndrome","volume":"15","author":"Chandra","year":"2008","journal-title":"Am J Ther"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib31","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/ard.2007.078915","article-title":"Efficacy of rituximab in Felty's syndrome","volume":"67","author":"Lekharaju","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jbspin.2008.02.018","article-title":"Efficacy of rituximab in Felty's syndrome","volume":"75","author":"Shipley","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib33","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2004.032110","article-title":"Etanercept in treatment of Felty's syndrome","volume":"64","author":"Ghavami","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/rheumatology\/keh128","article-title":"Case report: response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-alpha blockade","volume":"43","author":"Ravindran","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib35","first-page":"307","article-title":"Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome","volume":"39","author":"Starkerbaum","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib36","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/art.10497","article-title":"Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus","volume":"46","author":"Hellmich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/ard.34.2.156","article-title":"Granulopoietic activity in Felty's syndrome","volume":"34","author":"Gupta","year":"1975","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib38","first-page":"285","article-title":"The role of interleukin-8 and other cytokines in the pathogenesis of Felty's syndrome","volume":"13","author":"Meliconi","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.1780210304","article-title":"Comparison of the presence of immune complexes in Felty's syndrome and rheumatoid arthritis","volume":"21","author":"Andreis","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib40","doi-asserted-by":"crossref","first-page":"9234","DOI":"10.1073\/pnas.97.16.9234","article-title":"Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome","volume":"97","author":"Ditzel","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archinte.1978.03630280059020","article-title":"Splenectomy for Felty's syndrome","volume":"138","author":"Laszlo","year":"1978","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib42","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/1529-0131(200004)43:4<834::AID-ANR14>3.0.CO;2-H","article-title":"CD8+. CD57+ T-cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia in Felty's and large granular lymphocyte syndromes","volume":"43","author":"Coakley","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib43","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.2741\/2222","article-title":"Anti-CD20 therapy and autoimmune disease: therapeutic opportunities and evolving insights","volume":"12","author":"Silverman","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.semarthrit.2011.08.008_bib44","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2010.134684","article-title":"State-of-the-art: rheumatoid arthritis","volume":"69","author":"McInnes","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211002551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211002551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T06:50:58Z","timestamp":1543387858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017211002551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0049017211002551"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2011.08.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}